COVID-19 vaccine therapeutic trials review: published results and registered protocols

Osman, M.; Safer, M.; Hechaichi, A.; Letaief, H.; Dhaouadi, S.; Harizi, C.; Salah, H. B.; Derouiche, S.; Bouabid, L.; Bougatef, S.; Bouafif, N. B. A.

Osman, M.; Safer, M.; Hechaichi, A.; Letaief, H.; Dhaouadi, S.; Harizi, C.; Salah, H. B.; Derouiche, S.; Bouabid, L.; Bougatef, S.; Bouafif, N. B. A..

Journal of Global Health Reports ; 5(e2021019), 2021.

Article in English | GIM | ID: covidwho-1865723

ABSTRACT

ABSTRACT

Background:

Since the emerging of Coronavirus disease 2019 (COVID-19) in late 2019 and the World Health Organization (WHO) declaring it as a pandemic, a race to develop a vaccine against COVID-19 has started worldwide and therefore huge efforts and resources have been put into achieving it. This review summarizes COVID-19 vaccines in phase III and IV.

Keywords

coronavirus disease 2019; vaccines; pandemics; viral diseases; public health; disease prevention; immunization; human diseases; vaccination; BCG vaccine; clinical trials; measles; poliomyelitis; immune sensitization; Severe acute respiratory syndrome coronavirus 2; man; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; SARS-CoV-2; viral infections; polio

Fulltext

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: GIM Topics: Vaccines Language: English Journal: Journal of Global Health Reports Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google